Provider Assessment of Adherence to HIV Antiretroviral Therapy
The DOI matches its Crossref record.
Abstract
Summary: Mycophenolic acid (MPA) increases the activity of both abacavir (ABC) and didanosine (ddl) in vitro against wild-type and multinucleoside-resistant HIV. We treated 7 patients with diagnosed AIDS who did not respond to eight or more antiret roviral therapies in an open label pilot study with mycophenolate mofetil (MMF), ABC, ddl, amprenavir (APV), and ritonavir (RTV), with or without efavirenz (EFV). Therapy was well tolerated despite the patients' advanced disease states. No sig nificant decline in lymphocyte or other blood counts was observed. Median HIV RNA was 5.26 log10 copies/ml at entry, 4.53 log10 copies/ml at 4 weeks, and 5.13 log10 copies/ml at 16 weeks. Median CD4+ count was 34 cells/μl at entry and 39 cells/μl at 16 weeks of therapy. CD4+ counts increased further in five study subjects on extended therapy to 25 weeks (median 27 cells/μl at entry, 66 cells/μl at close), despite loss of virologic suppression in 4 of 5 cases. MPA can induce apoptosis in lymphocytes in vitro. However despite viral rebound, cell surface markers of apoptosis and activation declined in total CD3+ cells and CD3+/CD4+ cells twofold to fourfold in 4 of 5 adherent study subjects at 16 weeks, reaching levels comparable with those found in seronegative donors. Although low-dose MMF appears safe in late-stage HIV disease, this study did not demonstrate virologic efficacy. Higher doses of MMF may be more effective. With careful monitoring of toxicities and pharmacokinetics, MMF deserves further testing in HIV therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and AIDS in Botswana
Weiser, S., Wolfe, W., Bangsberg, D., Thior, I., Gilbert, P., Makhema, J., Kebaabetswe, P., Dickenson, D., Mompati, K., Essex, M., et al. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200311010-00004 · Cited by 473
Self-citationKnobel, H., Alonso, J., Casado, J. L., Collazos, J., González, J., Ruiz, I., Kindelan, J. M., Carmona, A., Juega, J., & Ocampo, A. (2002) · AIDS · doi:10.1097/00002030-200203080-00012 · Cited by 472
Optimal recall period and response task for self-reported HIV medication adherence
Lu, M., Safren, S. A., Skolnik, P. R., Rogers, W. H., Coady, W., Hardy, H., & Wilson, I. B. (2008) · AIDS and Behavior · doi:10.1007/s10461-007-9261-4 · Cited by 361
“Both clinical trials and cohort studies have shown that adherence to antiretroviral (ARV) medication is one of the most important factors for the success of HAART (Arnsten et al. 2001; Bangsberg et al. 2001; Chesney et al.1999; Paterson et al. 2000).”
BackgroundLucas, G. M., Gebo, K. A., Chaisson, R. E., & Moore, R. D. (2002) · AIDS · doi:10.1097/00002030-200203290-00012 · Cited by 320
Montgomery, P., Underhill, K., Gardner, F., Operario, D., & Mayo-Wilson, E. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.03.006 · Cited by 92
Metadata
- Authors
- Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M., & Moss, A.
- Venue
- Journal of Acquired Immune Deficiency Syndromes
- Published
- 2001-04
- Volume
- 26
- Issue
- 5
- Pages
- 435-442
- ISSN
- 1525-4135 (ISSN-L)
- OpenAlex
- W4241906316
- Cited by
- 97
- References
- 0
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Provider Assessment of Adherence to HIV Antiretroviral Therapy. https://app.cochat.ai/papers/10.1097/00042560-200104150-00005
- The paper
- Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M., & Moss, A. (2001). Provider Assessment of Adherence to HIV Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/00042560-200104150-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.